Ekso Bionics Holdings, Inc. (EKSO)
Market Closed
15 May, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
11. 80
-6.12
-34.15%
$
28.63M Market Cap
- P/E Ratio
- Div Yield
95,135 Volume
-1.29 Eps
$ 17.92
Previous Close Want to track EKSO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Ekso Bionics Holdings, Inc. (EKSO) Statistics
Valuation metrics
Market Cap 28.63M
Enterprise value 44.24M
Trailing P/E (ttm) -3.5
Forward P/E -62.11
PEG ratio -0.26
Price/Sales (ttm) 3.29
Price/Book (mrq) 4.65
Enterprise Value/Revenue 3.46
Enterprise Value/EBITDA -4.02
Overview
Shares outstanding 3.56M
Float 2.24M
Shares short 215.1K
% Held by insiders 0.25%
% Held by institutions 0.27%
Average volume (10 days) 440.2K
Average volume (90 days) 183.8K
Price summary
52-Week low 2.73
52-Week high 20.34
Beta 0.78
50-Day moving average 10.62
200-Day moving average 6.93
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:15
Last split Date 2 Jun 2025
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -0.91%
Operating margin -1.2%
Operational effectiveness
Return on assets -0.34%
Return on equity -1.08%
Income Statement
Revenue (ttm) 12.8M
Revenue per share (ttm) 5.28
Quarterly revenue growth (yoy) -0.38%
Gross profit (ttm) 6.84M
EBITDA -11M
Net income to common (ttm) -11.92M
Diluted EPS (ttm) -5.11
Quarterly earnings growth (yoy) -0.37%
Balance Sheet
Total cash (mrq) 1.17M
Total cash per share (mrq) 0.33
Total debt (mrq) 4.64M
Total Debt/Equity (mrq) 51.45
Current ratio (mrq) 1.63%
Book value per share (mrq) 2.54
Cash Flow
Cash flow statement -11.8M
Levered free cash flow (LFCF) -4.5M
